Therapeutic approaches in COVID-19 followed before arrival of any vaccine
- PMID: 34493973
- PMCID: PMC8413457
- DOI: 10.1016/j.matpr.2021.08.265
Therapeutic approaches in COVID-19 followed before arrival of any vaccine
Abstract
In present times covid-19 is spreading and is showing very destructive effects. It does not only affected the physical health but mental health as well as the economy of the major affected countries. Corona viruses are group of related RNA viruses. The first case of this virus was observed in China and then this virus got spread in the many countries and different strategies were made to stop the spread of this virus. Since no particular vaccine was available to cure this so different strategies were made. Due to the emergence of pandemic diseases, drug development and control strategies have been re-examined. One of the most important factors that scientists have to consider is the effectiveness of their drugs. This virus causes the respiratory tract infections which can range from mild to lethal. COVID-19 is a major cause of death in advanced countries. It is due to the absence of any particular vaccine that can effectively treat this condition. So in this review we will discuss about the therapeutic approaches followed to combat this deadly virus. Ayurveda, nitric oxide, nanoparticles and enzymes played a very important role in boosting the immunity and treatment of corona. Many herbs and some tips of using a combination of herbs proved to be very efficient while facing problems in breathing. Giving the dose of nitric oxide at some particular level and chloroquine the drug showed the antiviral activity against the virus. Developing methods to identify and contain COVID-19 is essential to successfully manage the virus. Various strains of the SARS-COV-2 were detected and were found more dangerous. The therapeutic approaches followed actually were efficient and can be used to combat the other variants also. This review focuses on the latest developments in the field of therapeutics and the strategies which were followed before any vaccine.
Keywords: MERS (Middle East respiratory disorder Covid); Nitric oxide (NO); SARS-CoV (serious intense respiratory condition Covid).
Copyright © 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the Symposium on Synthesis, Characterization & Processing of Inorganic, bio and nano Materials –2021.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Current Strategies of Antiviral Drug Discovery for COVID-19.Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021. Front Mol Biosci. 2021. PMID: 34055887 Free PMC article. Review.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
-
Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.Vaccine. 2020 Aug 10;38(36):5742-5746. doi: 10.1016/j.vaccine.2020.07.003. Epub 2020 Jul 11. Vaccine. 2020. PMID: 32684497 Free PMC article. Review.
-
Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.Mini Rev Med Chem. 2021;21(20):3191-3202. doi: 10.2174/1389557521666210225114733. Mini Rev Med Chem. 2021. PMID: 33632095 Review.
Cited by
-
Designing sustainable cement free compositions with rice husk ash to improve mechanical performance in next generation ecoblocks.Sci Rep. 2025 Apr 28;15(1):14920. doi: 10.1038/s41598-025-97963-8. Sci Rep. 2025. PMID: 40295560 Free PMC article.
-
Multivariable analysis of clinical and laboratory data manifestations predicting severity and mortality risk in patients with Coronavirus disease 2019 in the mountainous west of Iran: a retrospective single-center study.Asian Biomed (Res Rev News). 2022 Feb 28;16(1):31-42. doi: 10.2478/abm-2022-0005. eCollection 2022 Feb. Asian Biomed (Res Rev News). 2022. PMID: 37551398 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous